BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10215560)

  • 1. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
    Rodeghiero F; Tosetto A
    Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.
    Mingozzi F; Legnani C; Lunghi B; Scanavini D; Castoldi E; Palareti G; Marchetti G; Bernardi F
    Thromb Haemost; 2003 Jun; 89(6):983-9. PubMed ID: 12783110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
    Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
    Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
    Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
    J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
    Spannagl M; Heinemann LA; Schramm W
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
    Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
    Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
    Haim N; Lanir N; Hoffman R; Haim A; Tsalik M; Brenner B
    Am J Med; 2001 Feb; 110(2):91-6. PubMed ID: 11165549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
    Strandberg K; Stenflo J; Nilsson C; Svensson PJ
    J Thromb Haemost; 2005 Nov; 3(11):2578-80. PubMed ID: 16241958
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ; Wang P; Fontaine RN; Tracy T; Sieve-Smith L; Lang JE
    Am J Cardiol; 1999 Sep; 84(5):549-54. PubMed ID: 10482153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
    Middeldorp S; Henkens CM; Koopman MM; van Pampus EC; Hamulyák K; van der Meer J; Prins MH; Büller HR
    Ann Intern Med; 1998 Jan; 128(1):15-20. PubMed ID: 9424976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
    Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
    Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
    Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Br J Haematol; 2002 Mar; 116(3):625-31. PubMed ID: 11849222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.